Brief: IGM Biosciences Announces Fourth Quarter And Full Year 2023 Financial Results
07/03/2024 21:14
March 7 (Reuters) - IGM Biosciences Inc IGMS.O :
* IGM BIOSCIENCES ANNOUNCES FOURTH QUARTER AND FULL YEAR
2023
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* IGM BIOSCIENCES INC - CASH AND INVESTMENTS AS OF DECEMBER
31,
2023 WERE $337.7 MILLION
* IGM BIOSCIENCES INC - EXPECTS FULL YEAR 2024 GAAP
OPERATING
EXPENSES OF $210 MILLION TO $220 MILLION
* IGM BIOSCIENCES - SEES TO END 2024 WITH A BALANCE OF ABOUT
$180
MILLION IN CASH AND INVESTMENTS
* IGM BIOSCIENCES - SEES CASH BALANCE TO ENABLE IT TO FUND
OPERATING EXPENSES AND CAPITAL EXPENDITURE REQUIREMENTS INTO Q2
OF 2026
Source text for Eikon: ID:nGNX7TJCHz
Further company coverage: IGMS.O
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary